APA (7th ed.) Citation

FA, M., S, O., MEH, H., KC, H., KJ, B., & MN, N. (2009). The role of KRAS mutation testing in the management of patients with metastatic colorectal cancer. Archives of Pathology & Laboratory Medicine, 133(10), 1600. https://doi.org/10.5858/133.10.1600

Chicago Style (17th ed.) Citation

FA, Monzon, Ogino S, Hammond MEH, Halling KC, Bloom KJ, and Nikiforova MN. "The Role of KRAS Mutation Testing in the Management of Patients with Metastatic Colorectal Cancer." Archives of Pathology & Laboratory Medicine 133, no. 10 (2009): 1600. https://doi.org/10.5858/133.10.1600.

MLA (9th ed.) Citation

FA, Monzon, et al. "The Role of KRAS Mutation Testing in the Management of Patients with Metastatic Colorectal Cancer." Archives of Pathology & Laboratory Medicine, vol. 133, no. 10, 2009, p. 1600, https://doi.org/10.5858/133.10.1600.